Efavirenz
- Product NDC
- 65862-774
- 11-digit product format
- 658620774
- Labeler code
- 65862
- Product ID
- 65862-774_eba5118d-9e41-40bc-87bc-e2a61ff044a0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Efavirenz
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Aurobindo Pharma Limited
- Application
- ANDA205322
- Marketing category
- ANDA
- Marketing start
- 2018-08-30
- Marketing end
- 0000-00-00
- Substance
- EFAVIRENZ
- Active strength
- 600 mg/1
- Pharmacologic classes
- Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [EXT],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C9 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 65862-774-30 | 65862077430 | 30 TABLET, FILM COATED in 1 BOTTLE (65862-774-30) | 2018-08-30 | 0000-00-00 | No | No | Current |